体成分对系统性硬化症患者是否重要
纳入87例系统性硬化症患者,通过胸部高分辨率CT第12胸椎水平半自动分割皮下脂肪和椎旁肌,评估体成分与死亡率的关系。线性回归显示较低DLCO、较高BMI、较高皮下脂肪密度和较低骨骼肌指数为死亡预测因素;72%患者存在肌脂肪变性,其死亡风险比为3.345(95%CI 0.396-28.295)。
要点
- 较低DLCO、较高BMI、较高皮下脂肪密度和较低骨骼肌指数为死亡预测因素。
- 72%的系统性硬化症患者存在肌脂肪变性(Hu<30)。
- 肌脂肪变性患者死亡风险比为3.345(95%CI 0.396-28.295)。
核心结论
- 系统性硬化症患者存在肌脂肪变性和前肌肉减少症,体成分似乎影响总体结局。
研究设计与样本
- 研究纳入转诊至三级中心的成人系统性硬化症患者,均接受高分辨率胸部CT评估肺部受累,共87例(77例女性,年龄60±15岁,61%为局限性皮肤型系统性硬化症)。
- 在第12胸椎水平对皮下脂肪和椎旁肌进行半自动分割,收集皮下脂肪和椎旁肌面积及密度等体成分指标。
- 采用逐步线性回归分析评估体成分、人口学和肺功能检查对死亡率的预测作用;将肌肉Hu值<30定义为肌脂肪变性,使用比值比评估其与死亡风险的关联。
主要发现
- 线性模型显示较低DLCO(P=0.047)、较高BMI(P=0.013)、较高皮下脂肪密度(P=0.005)和较低骨骼肌指数(P<0.001)为死亡预测因素。
- 63例患者(72%)存在肌脂肪变性(即Hu<30 Hu),CT显示肌肉脂肪浸润的患者死亡风险比为3.345(95%CI 0.396-28.295)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Body composition plays a significant role in various rheumatic and autoinflammatory diseases. The aim of our study was to assess the impact of muscle mass and subcutaneous adipose tissue quality and quantity in patients with SSc. METHODS: Adults with SSc referring to our tertiary centre who underwent high-resolution chest CT (HRCT) to assess pulmonary involvement were included. A semi-automatic segmentation of the subcutaneous fat and paravertebral muscle was performed at the level of the 12th dorsal vertebra, and body composition metrics were collected (subcutaneous fat and paravertebral muscle area and density). Stepwise linear regression analysis was applied to evaluate if body composition, demographics and pulmonary function tests acted as predictors of mortality. Considering patients with muscle Hu values <30 as affected by myosteatosis, we used the odds-risk ratio to assess if it is associated with a higher risk of mortality. RESULTS: Eighty-seven SSc patients (77 females, age 60 ± 15 years, 61% affected by limited cutaneous SSc) were included. The linear model demonstrated that lower DLCO (P = 0.047), higher BMI (P = 0.013), higher density of the subcutaneous fat (P = 0.005) and lower skeletal muscle index (P < 0.001) acted as predictors of mortality. Overall, 63 patients (72%) were affected by myosteatosis (i.e. Hu <30 Hu) and patients affected by muscle fat infiltration at CT showed a 3.345 times higher mortality risk (95% CI 0.396-28.295). CONCLUSION: Patients with SSc are affected by myosteatosis and pre-sarcopenia and body composition seems to influence the overall outcome.
引用
- Giraudo C, Fichera G, Binda M, et al. Does body composition matter in patients with systemic sclerosis? Rheumatology (Oxford). 2025. PMID: 40408236. doi:10.1093/rheumatology/keaf283
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。